NCT07119424 Multidisciplinary Dissection of Renal and Metabolic Effects of Glyfozines on Elderly Patients: From Molecular Aspects to Clinical Indications
| NCT ID | NCT07119424 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chiara Lanzani |
| Condition | Elderly Patients (>65 Years) |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-02-14 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2025-02-14 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The project aims to study the impact of SGLT2i therapy on clinical and biochemical aspects. in elderly. The project will combine different types of data, such as clinical and biological information, and will use advanced Bayesian statistical methods to understand the relationship between risk factors and patient outcomes following treatment with SGLT2 inhibitors.
Eligibility Criteria
Inclusion Criteria: 1. Participant is willing and able to give informed consent for participation in the study; 2. Patients must be enrolled also in MED-Cli e MED-Mol studies by signing both the MED-Cli e MED-Mol informed consents. 3. The medical product is the standard of care for the patient and has been prescribed according to clinical practice and independent of the present study; 4. Age ≥65 years; 5. Participant has not yet started the prescribed SGLT2i therapy; 6. Participant has at least one clinical indication for SGLT2i use according to clinical practice guidelines. Exclusion Criteria: 1. Current or previous use of SGLT2i; 2. Inability to sign the informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07119424 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Elderly Patients (>65 Years). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07119424 currently recruiting?
Yes, NCT07119424 is actively recruiting participants. Contact the research team at lanzani.chiara@hsr.it for enrollment information.
Where is the NCT07119424 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT07119424 clinical trial?
NCT07119424 is sponsored by Chiara Lanzani. The trial plans to enroll 300 participants.